chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Shingles / Suspected vaccination failure; Had shingles; Some of the itching; Eye issues; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: Had shingles), pruritus (Verbatim: Some of the itching) and eye disorder (Verbatim: Eye issues). The outcome of the vaccination failure was unknown and the outcome of the shingles, pruritus and eye disorder were not reported.   It was unknown if the reporter considered the vaccination failure, shingles, pruritus and eye disorder to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles, pruritus and eye disorder to be related to Shingles vaccine.   Additional Information: GSK receipt date: 25-MAR-2023 This case was reported by a patient via interactive digital media. The patient reported that, when you have had shingles, you darn sure know what it was.  Took them awhile to admit, no guaranteed shots prevent, no guarantee or for sure how long the side effects continue, and on and on. The reporter just did not know enough about it.   The reporter stated that, still got side effects, some of the itching, eye issues etc. some of the symptoms mirror other medical issues but everything seems to overlap these days. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
The pt experienced debilitating fatigue, excruciating joint pain throughout entire body, chills, headache, and fever. The pt also experienced loss of appetite. 60 day follow-up states the pt had high liver function, muscle weakness and joint aches.
Severe menstral symptoms: Monthly menstral cycle has become more painful and bleeding has increased. Cramps are more severe as well as breast extreme tenderness.
No additional AE/PQC reported; administered the second dose too early/ First dose was adminitered on 17-JAN-2023 and the second dose was given 2 months early on 22-MAY-2023.; This spontaneous report has been received from a consumer and refers to a patient of unknown age and gender.  The patient's pertinent medical, other drug reactions or allergies, concurrent conditions and concomitant therapies were not reported.  On 17-JAN-2023, the patient was vaccinated with the first dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, and had the second dose of hepatitis a vaccine, inactivated (VAQTA) administered  two months early, on 22-MAY-2023 (inappropriate schedule of product administration); both doses administered for prophylaxis (strength, lot #, expiry date, and anatomical route of administration were not provided). No other adverse events were reported.
At present Chest Pain since 1/2 hour after vaccination now occurring 5+ days .  Anxiety present over symptoms for hour after vaccination. Body aches and soreness at injection site  present on 11th only. Headaches on and off still present. Insomnia in relation to chest pain.
I missed 6 month deadline for second shot; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (1st dose received on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were reported as follows: The case was self reported by the patient. The age at vaccination was not applicable. The patient missed 6 month deadline for second shot of Shingles vaccine, which led to incomplete course of vaccination.  The patient was asking could he/she still get second shot of Shingles vaccine.
Patient presented to pharmacy Sunday 5/10/15 after receiving ADACEL vaccine on 5/7/15. Patient's arm was covered in a dark real purple rash from her  shoulder to the crook of her elbow. She reported her whole arm was very itchy. She also reported beginning to feel extremely fatigued the Friday evening after her vaccine. Reports that she slept 20 hours straight through Saturday 5/9.
Fatigue through the late morning afternoon. Around 9pm - the injection site started to swell. There was pain and some itching, redness. Pain was soreness. I took diphenhydramine 25 mg  prior to going to bed and iced the site of the injection for about 10 minutes around 11pm. This morning the injection site remains sore, red, and swollen, a little itching, but it is improved.
tiredness; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tiredness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (tiredness). At the time of the report, FATIGUE (tiredness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  There was no treatment reported.
I received the covid vaccine in my left arm yesterday morning at 8:00 am.   I felt fine until noon when my arm became sore, which I expected to happen so I took Tylenol.  By mid afternoon, my 4th and 5th finger on my left had began to tingle and I was having difficult typing with that hand on my keyboard.  By late afternoon, the left side of my face began to tingle like paresthesia.    I took more Tylenol at dinner but the sensation in my face lasted until I went to bed around 10:00.   I woke up in the night and my face felt fine but my 2 fingers were still tingling and I felt like I had no control over them.   When I woke up this morning, I took to more Tylenol and the symptoms have subsided. Also, when the nurse swabbed my arm with alcohol, I asked?Isn?t that a little high for the injection, and he said no?it?s right in the deltoid.   It felt like the injection site was close to the bones in my shoulder but that may have had nothing to do with these symptoms.
Left arm is painful, sore, unable to raise it, rash, sore mouth, and unable to turn wrist.
Cough, fever, chills, fatigue, sneezing  for the past 62 hours.
This spontaneous report was received from a nurse practitioner and refers to a patient of unknown age and gender. On 02-MAY-2012, the patient was vaccinated with the first dose of improperly stored VARIVAX, lot#: 1273AA. On 15-JUN-2012, the patient was vaccinated with second dose of improperly stored VARIVAX lot#: 671861/1907AA. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
A non-serious spontaneous report of inadvertently gave FLUMIST to a pregnant female was received from a health professional concerning an 18-year-old female. Neither relevant past medical history, concomitant medications nor obstetrical history were reported for this patient. The patient was inadvertently given FLUMIST on 25-Oct-2011. There was no adverse event associated with this pregnancy and the event was considered to be resolved. Treatment and reporter causality assessments are not applicable. The reporter was asked to inform when the pregnancy has ended and also to inform if the patient experiences any adverse events during the pregnancy.
bloody urine after getting SHINGRIX; This non-serious case was reported by a consumer via call center representative and described the occurrence of hematuria in a 75-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included hematuria (had a history of bloody urine after certain medications).   On 09-AUG-2023, the patient received the 2nd dose of Shingrix. On 10-AUG-2023, 1 days after receiving Shingrix, the patient experienced hematuria (Verbatim: bloody urine after getting SHINGRIX). On 11-AUG-2023, the outcome of the hematuria was resolved (duration 24 hrs).   It was unknown if the reporter considered the hematuria to be related to Shingrix.     It was unknown if the company considered the hematuria to be related to Shingrix.   Additional Information: GSK receipt date: 11-Aug-2023 The patient received a dose of Shingrix and stated that next morning she had bloody urine. Spoken as per package inset and offered package insert. Medical information phone number was provided. Referred to health care professional.  The reporter did not consent to follow-up.
Almost immediately I had tingling, itchy lips and a weird taste in throat (best described as medicine & metal. Almost like prescription Lidocaine tastes like). Within 10 minutes I started to feel very lightheaded & dizzy. Waved a nurse over to check my blood pressure. I had high blood pressure and a high heart rate, lips and face were itchy and I felt very dizzy/light headed.
No wheezes, rales, rhonchi or respiratory distress, temperature 99.9, P 140, R 30 at urgent care appoint they day following large urticaria on right buttocks and face that began during the night after immunizations received. Turned to hives generalized, unknown which vaccine responsible for reaction.
This is a follow-up to a previously submitted VAERS report this 47 year old patient received 4 BIOTHRAX prior to and during his deployment in 2003. His concerns centered on whether the BIOTHRAX contributed to mental (depression, memory, fatigue) and physical disorders (joint pain, skin discoloration, rash) that "began in 2003".
First experienced soreness at injection site after receiving the vaccine. Then at around 6:00 I began feeling pain/aches all over my body as well as chills. Around 9:00pm I got a headache. Chills went away a few hours later but the aches were extreme and persisted until around 2:00pm on the March 17. Also experienced fatigue.
5-6 HOURS AFTER VACCINATION.  CONVULSIONS/SEIZURE, HIGH BLOOD PRESSURE, INCREASED HEART RATE,
Information has been received from a physician concerning a patient who was vaccinated with a dose of Gardasil (lot number unknown). The physician reported that the patient experienced pain at the injection site after receiving the Gardasil routinely; however she had not had any issues with patients coming back for the second and third injections. The outcome was unknown. Additional information was received from the office manager via phone call who reported that the pain did not linger. Additional information has been requested.
This spontaneous report as received from a consumer (also reported as healthcare student) of 23 year old female patient refers to herself. Patient medical history and current condition was not reported. Approximately in JULY-2014 (reported as six months before December 17th, 2014), the patient was vaccinated with GARDASIL dose 2 vaccination. Other co-suspects and concomitant medication was not reported. Approximately in DECEMBER-2014 (reported as about the second week in DECEMBER-2014) the patient experienced right ear infection. Also reported that it was a normal ear infection. The patient was prescribed an antibiotic (unspecified) and Fluticasone nasal spray. It was reported that the patient has finished the antibiotic therapy but not the nasal spray. Also states that she was still congested. It was reported that she did not take the Fluticasone nasal spray the previous day or the present day (reported as yesterday or today), because she wants to get the third dose of GARDASIL. The outcome of the event was reported as not recovered/not resolved. The reporter states the event was not caused by the GARDASIL. Additional information has been requested.
Soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Soreness) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, the patient experienced PAIN (Soreness). At the time of the report, PAIN (Soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
This spontaneous report was received from a pharmacist and refers to a neonate patient reported as ''newborn'' of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 18-SEP-2018, the patient was vaccinated with RECOMBIVAX HB (dose, lot #, expiration date, site and route of administration were not reported) for prophylaxis. At the same time, the patient received in the same leg unspecified hepatitis B immune globulin (product administered at inappropriate site). No adverse effect were reported.
12 hours after vaccine - anxious, fever, chills, body aches. 15 days later claims to still not feel right
1 1/2' x 2' erythematous warm, swollen area to (L) arm.
Myalgia, Diarrhea, NauseaVomiting, sore throat. had positive covid test initially and then 2 subsequent covid tests were negative. considered a false positive.  Narrative:
First shot 10/23/2014 and 2nd shot 04/23/2015 no pain at all. Pain began with the last shot. At the injection site, hard lump, tenderness, nagging bruise like ache, right shoulder joint cracks all the times. Still tender this day hour.
I felt like I could run a marathon, up most of the night after the injection, all the next day and up most of the second night.  Other than that, felt ok.  A lot of energy!!!!
Local reaction, painful, swollen, mildly red 13 x 13cm. Left upper arm.
This patient received dose 1 on 6/1/21 and dose 2 on 6/22/21 at another facility.  She was given a booster vaccine of Pfizer 0.3 mL IM on 12/03/2021.
On the day after second dose, patient experienced new onset horizontal double vision which has not resolved over the course of the past 20 days
administration of expired Moderna vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administration of expired Moderna vaccine) in a 39-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administration of expired Moderna vaccine). On 02-Dec-2021, EXPIRED PRODUCT ADMINISTERED (administration of expired Moderna vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.   No treatment was given to the patient.   The vaccines were stored in freezer, were taken out one to two vials and placed in fridge each day as needed.
Pain and redness above middle finger on top of hand in right arm 3 days after injection. Increased redness and swelling noted
Patient began to experience nausea, dizziness, generalized weakness, and an elevated blood pressure (209/101) approximately 5 minutes after receiving the 2nd dose of the COVID-19 vaccine.  The patient was taken to the emergency department for further workup. In the ED, the patient was given acetaminophen and ondansetron. Workup was negative, and the patient was discharged home.
Pfizer-BioNTech cOVID-19 vaccine EUA Swelling of hands, swelling of lips, hives from neck to knees. 3-6 days after injection Resolved using Benadryl, ice, cortisone cream, ibuprofen.
PARTIAL DOSE ADMINISTERED; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 05-MAY-2021 for prophylactic vaccination. Batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced partial dose administered. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of partial dose administered was not reported. This report was non-serious.
Hives covering the chest, arms, neck, ears , and entire face. A day after vaccine.
Pt has had ongoing issues with taste and smell since shortly after getting the first dose of the Pfizer vaccine on 5/15/2021. First recorded date was on 5/18/2021. Certain foods that he really enjoyed eating prior to vaccination including eggs and Goldfish crackers, smell and taste horrible.
Patient reports that within thirty minutes after receiving the vaccine she experienced an increased heart rate, flushing, dizziness and a subsequent itchy collarbone rash.  All symptoms gone by morning.
Patient reported having chest pain the morning following the second dose of SHINGRIX vaccine lasting several minutes. Other symptoms reported include arm redness and swelling as well as headache.
Information has been received from a Licensed Practical Nurse concerning an unspecified numbers of patients. On an unspecified date, the patients received a batch of improperly stored PEDVAXHIB (dose, strength, route and lot# were not reported). No adverse effects reported. Follow up information has been received on 01-APR-2015 from the Licensed Practical Nurse via a telephone call. The lot number and expiration date for the PEDVAXHIB vaccination was provided: lot number: K002818, expiration date: 10-DEC-2016. The nurse reported that patient identification information was not readily available at the time of the call and there were no reported adverse events. This case was one of the 7 reports received from the same reporter (other two products were captured in case 1502USA005910, 1503USA003159, 1504USA002730 and 1504USA002731; the other two reports concerning the same product was captured in 1504USA003188 and 1503USA003160). Additional information has been requested. Product and narrative were updated.
received shot on Thursday evening, Saturday morning I started feeling swelling and pain under armpit, associated with chest/ breast pain. as per my employee covid center on Monday symptoms were still present as per command center seek medical attention. on monday evening i went to see my primary who told me lymph node pain and swelling is expected after vaccination. pain and swelling is still noted 6 days later.
sz kept vomiting APAP suspension when given to pt; taken to ER; tolerated APAP suppositories w/o further incidence;
This case was reported by a pharmacist via call center representative and described the occurrence of fatigue in a 68-year-old male patient who received SHINGRIX (batch number B327C, expiry date 4th January 2020). On 12th April 2018, the patient received the 1st dose of SHINGRIX .5 ml. In April 2018, less than a week after receiving SHINGRIX, the patient experienced rash. On 16th April 2018, the patient experienced fatigue, chills, fever, nausea and influenza-like symptoms. In April 2018, the outcome of the fatigue, chills, fever, nausea and influenza-like symptoms were recovered/resolved. On an unknown date, the outcome of the rash was not recovered/not resolved. It was unknown if the reporter considered the fatigue, chills, fever, nausea, influenza-like symptoms and rash to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX in left deltoid. Four days after vaccination, the patient experienced fatigue, chills, fever, nausea and influenza-like symptoms. An actual temperature was not provided. The patient said he felt feverish. The patient stated that his flu like symptoms had resolved, however he had not developed a rash on his neck along the same side that he had the SHINGRIX injection.
Patient  had outbreak of shingles in her right ear and right side of face.  Shingles started started on 6/15/19 after vaccination on 6/12/19.
Swelling of left arm, left leg and right leg.  Sore joint in left hand.  Hand swelling lasted for over 12 hours.  Swelling in legs lasted for up to 5 days.  Headache that lasted 4-5 hours.  Treatment: took Benadryl and Advil.
LUE pain, redness, swelling, erythema s/p Pneumo23 vaccine at approx 0800 redness starts 12cm below injection site. T 100.6 temporal.
Pfizer COVID-19 Vaccine EUA  Pt received 2nd dose of vaccine at 1648. At 1700, pt reports slight dizziness 128/82, pulse ox 100, pulse 60. Denies respiratory distress, difficulty breathing. Urticaria absent. At 1715, 130/86, pulse ox 100, pulse 60 post oral fluids. Unchanged dizziness. Transferred to  care.  At  care, pt presents with minimal lightheadedness/dizziness. Pt reports history of vertigo that has been triggered by fatigue. Pt thinks her reaction is due to a long day at work with difficult situations - she was very fatigued at the end of her shift, before she received her 2nd vaccine dose. Pt states she feels like she is about to get vertigo, but it never actually happens. Pt denies tongue swelling, lip swelling, or feeling like her throat is closing off. No rash, hives, itching. Pt discharged after about 30 minutes.
Pt c/o Left thumb cramps/pain 3/10.  C/o fatigue.  Lying BP 101/64, HR 73, RR 18 -- > 112/70, 79, 18.  Sitting BP 156/82, HR 101, RR 18.  Instructed pt to push fluids and rest.  Pt may take Tylenol or, if not expecting, ibuprofen.  Rest Left arm/hand.  May use ice pack or heat 15min on/off.  Pt stable and released from the vaccination site.  Recommended that the pt f/u w/ their healthcare provider.
Severe headache beginning in late afternoon on 10/2/23 Severe vomiting  and diarrhea, fever, beginning approx 2am 10/3/22 ending late evening 10/4/22 Severe fatigue beginning late afternoon 10/2/22 through 10/6/22 Unable to eat or drink from 10/3/22-10/4/22
Pt. reported pain swelling (L) deltoid swelling to 2x normal size by evening after injection. Swelling/edema moved down arm now to just below elbow.
This spontaneous report was received from a licensed practical nurse and refers to an unspecified number of patients of unknown age and gender. No information about the patients' pertinent medical history, concomitant medications and drug reactions or allergies was reported. On an unknown dates, the patients were vaccinated with improperly stored doses of PROQUAD injection, lot # M017335, expiry date 05-OCT-2017 (therapy type, dose, route of administration and anatomical location were not specified). The administered doses of PROQUAD underwent temperature excursion under 13.3 Fahrenheit degrees for 7.5 hours in the freezer and 62.6 Fahrenheit degrees for 10 hours in the refrigerator. No prior excursions were reported. No adverse effects were reported. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.